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FLATOXIN-CONTAMINATED groundnut meal
is known to induce marked hepatic
damage in various species of animals (1-3).
The subacute toxic effects of these fungal
metabolites in primates have been reported
from these Laboratories (4). To date there is
no direct evidence to suggest that man has
suffered ill effects through consumption of
aflatoxic groundnuts or groundnut products.
The high prevalence of hepatic cirrhosis in
certain parts of India where groundnut is
grown and consumed has been suggested as
being indicative of the effects of aflatoxin on
humans. There have also been suggestions
that aflatoxin may perhaps be implicated in
the development of primary carcinoma in
man (5). Recently, the problem was investi-
gated by Robinson (6). In view of the ap-
parent similarity in the fluorescent property
of aflatoxin B1 and a compound appearing in
the urine of cirrhotic children, it has been
suggested that afiatoxin may be causally re-
lated to the liver condition. Some workers
have shown that aflatoxin B1 administered
orally to rats (7), sheep (8), and cows (9)
appears in urine, milk, and the liver in the
form of a metabolite having fluorescent
property and biological activity similar to the
parent toxin. In the present investigation,
the urine and liver of patients suffering from
Indian childhood cirrhosis and the milk
samples collected from their mothers have
been examined for the presence of aflatoxin.
1 From the Nutrition Research Laboratories, In-
than Council of Medical Research, Tarnaka, Hy-
derabad-7, India.
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MATERIALS AND METHODS
Subjects. Sixteen patients whose ages ranged from
3 months to 2.5 years with histologically proved
diagnosis of Indian childhood cirrhosis were in-
vestigated. They were admitted to the hospital at
various stages of severity of the disease.
All the children had been treated prior to ad-
mission with various drugs including broad-spec-
trum antibiotics, corticosteroids, and diuretics.
Many of them had also received various types of
indigenous drugs. They continued to receive the
steroids and antibiotics during their stay in the
hospital.
Diet history. Three infants under 1 year were
entirely breast fed, whereas the others received a
mixed diet. Mothers were specifically questioned
regarding the consumption of groundnut by the
children. Except in one case, there was no history of
groundnut intake. As there is a possibility of an
infant receiving the toxin through the mother’s
milk, breast milk samples were also collected from
some of the mothers for analysis.
Clinical features. The patients could be graded
into three categories depending on the clinical
manifestations.
Grade I. The symptoms were vague and the
children were brought to the hospital for some
gastrointestinal disturbances or low grade fever.
The only positive finding on examination was an
enlarged, firm liver.
Grade II. The clinical findings were more defi-
nite. The child failed to thrive, had pitting edema
of the lower extremities, and was undernourished.
The abdomen was prominent with obviously en-
larged veins; the liver was firm, markedly enlarged,
and had the characteristic “leafy edge”; and the
spleen was palpable.
Grade III. In this advanced stage, the abdomen
was grossly protuberant because of ascites. The
spleen was large and firm and the liver when
 by on O
ctober 7, 2010 
w
w
w
.ajcn.org
D
ow
nloaded from
 
Aflatoxin and Childhood Cirrhosis 95
palpable was firm with a sharp margin. Persistent
fever with jaundice and generalized anasarca with
or without hemorrhagic phenomena were present.
Histopathologicalfindings. A liver biopsy specimen
showed varying degrees of cell destruction, fibrosis,
inflammatory cell infiltration, and regenerating
nodules. The cells were swollen and there was a
clumping of cytoplasmic contents; the nuclei were
pyknotic in some and absent in others. Mallory
bodies and bird’s eye nuclei were present in some
sections. The liver tissue was seen to be divided
into multiple small round or oval pseudolobules
by fibrous tissue septa of variable thickness. In
some cases, there was complete loss of architec-
tural pattern with progressive cell destruction,
collapse of reticular framework, and extensive
fibrosis. Portal tracts exhibited varying degrees of
cell infiltration.
Twenty-four-hour urinary collections were
made in all subjects. Two patients with grade III
manifestations died of hepatic coma within a week
after admission. In one of them necropsy was done
and a sample of the liver examined for presence of
aflatoxin.
Eleven patients with other liver disorders and
six normal patients were also studied.
Extraction and Estimation Procedures
The 24-hr urine sample collected over 5 ml HCI
was concentrated to 50 ml in a porcelain dish on a
hot water bath. An equal volume of methanol was
added and any precipitate formed was separated
by filtration. The filtrate was extracted thrice,
each time with 25 ml chloroform. The chloroform
extract was then concentrated to 5 ml and applied
on a silica column. It was eluted first with ethyl
ether to remove coloring matter and fluorescent
impurities and then with chloroform containing
2% methanol to elute aflatoxin and its metabolites,
if present. The extracts were concentrated and
aliquot portions spotted on chromatoplates for
examination of aflatoxin by the method of de Iongh
et al. (10) using 5% methanol in chloroform as the
developing solvent. A similar procedure was
adopted for the extracts of liver specimens. Solu-
tion of pure aflatoxin B1 was used as a reference
standard, which was spotted on the same plate
along with the urine and liver extracts for corn-
parison.
The dry, developed chromatoplate was ex-
amined under long-wave ultraviolet light for the
presence of blue-violet fluorescent spot of R, 0.56,
corresponding to aflatoxin B1. For further physico-
chemical examination, these spots were individ-
ually eluted with chloroform and subjected to
ultraviolet, infrared, and fluorescent spectroscopy.
The ultraviolet absorption spectrum was deter-
mined on a Beckman DB recording spectropho-
tometer from 250 to 450 mi. Infrared spectra were
obtained on a Perkin-Elmer infrared spectro-
photometer, model 221 . Fluorescence characteris-
tics of the urinary spot were studied by measuring
the emission and absorption spectra of the solution
in chloroform in the ultraviolet region using a
spectrofluororneter (Farrand Optical Co., Inc.,
N.Y.) with an attached graphic recorder, and they
were compared with the fluorescent properties of
aflatoxin B1.
Biological Testing
Day-old ducklings were used for testing the
toxicity of the fluorescent compounds appearing
in the urine of cirrhotic patients. The experimental
birds were housed in electric brooders and fed a
laboratory duckling mash. Control birds as well as
birds given 10 ig aflatoxin Bi/day were examined
with each batch of experimental ducklings that
received orally the fluorescent material extracted
from the chrornatoplate. Propylene glycol served
as the medium in which the compound s%-as dis-
solved for administration. The control birds re-
ceived an equal amount of propylene glycol alone.
Feeding of the extracts was continued for 5 con-
secutive days after which the experimental and
control birds were killed and their livers processed
for histopathological examination.
RESULTS AND DISCUSSION
Presence of a compound that gave the spot. Ten
of sixteen children with Indian childhood
cirrhosis had a compound in their urine
that gave a fluorescent spot. Of the six that
did not have this spot, four children had
grade I cirrhosis and two had grade II cirrhosis.
Most of the grade II and all grade III cirrhosis
had the spot (Table i). One out of two having
posthepatitic cirrhosis in childhood and both
adult hepatic cirrhosis patients had the spot.
Of seven children with nonspecific hepato-
megaly, three urmnes were positive, whereas
none of the six normal children showed the
spot (Table ix). All four samples of milk
examined were negative.
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T I
Data on children with Indian childhood cirrhosis
Name Age, years Duration ofillness, montiss Severity grade Jaundice Liver Spleen
Fluorescent
spot in urine
A 912 1 I ± +-- ± - -
PK 1 4 I - ++ ± - -
S
2 1 I - ++ - - -
C 1642 3 1 ± ++ - - -
1 ‘i2 4 II - ++++ + - -
CS 2 3 II ± +++ + - -
M 22 2 II - ++++ ++ - +
M 2 4 II - +++ +
- +
Tn 2 1 II ± +++ - - --
P 12 3 II - +++ + - +
N 1642 4 II - +++ + - +
T 1 2 III + ++++ + + +
M 2 6 III + +++ + + +
Sr 1/j2 6 III + +++ ++ + +
Sh 19i2 8 III + ++++ ++ + +
BS l2 4 III + ++++ ++ + +
TABLE II
Types of subjects studied for the presence
of aflatoxin in urine
Disease Number
examined
Number
showing a
fluorescent
spot
Indian childhood cirrhosis
Posthepatitic cirrhosis
Adult cirrhosis
Other hepatomegalies
Normals
16
2
2
7
6
10
1
2
3
0
Ultraviolet absorption spectrum. The ultra-
violet spectra of the substance in the urine
exhibiting violet-blue fluorescence and of
afiatoxin B1 are given in Fig. 1 . Aflatoxin B1
showed the peaks of absorption at 223, 265,
and 363 mz, the latter being most prominent.
The urinary compound showed only one peak
at 270 mj, which is quite different from that
of aflatoxin B1.
Fluorescence spectra. The pattern of fluores-
cence spectra of the urinary compound and
aflatoxin B1 were measured with a view to
finding out the maximum fluorescence in-
tensities of the two compounds in chloroform
solution. The measurements were made in
arbitrary units.
Freshly prepared solutions of the recrystal-
lized material were used and the concentra-
tions adjusted in the range where a linear
relationship existed between concentration
and fluorescence intensity. Fluorescence spec-
trum and the emission spectrum of pure afla-
toxin and the urinary compound were ob-
tamed using the excitation wave length
between 210 and 425 mis.
z
0
I-
0.
0
.0
4
Fic. 1. Ultraviolet spectra ofaflatoxin B1 (- - -
and the compound present in urine and in liver of
cirrhotic children (--).
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It can be seen from Fig. 2 that both afla-
toxin B1 and the urinary compound showed
the emission maxima at 425 m, whereas the
excitation maxima were 365 ms for aflatoxin
B1 and 310 m for the urinary compound.
Identical values for emission maxima for the
two compounds confirmed the similarity in
their chromatic property of fluorescence. On
the other hand, the difference in the excita-
tion maxima suggested differences in their
chemical nature.
Infrared absorption spectra. The infrared ab-
sorption spectrum of aflatoxin B1 in chioro-
form has been studied by Hartley et al. (1 1).
The characteristic spectrum indicated the ab-
sence of OH group unless chelated and
showed two peaks in the carbonyl region at
1,755 cm and 1,688 cm (a)250D =
- 562 ± 15 (C, 0. 1 15 in chloroform). It also
showed characteristic peaks for difurano ring
and for the coumarin structure.
The patterns of infrared absorption spectra
of the urinary and liver compounds (Fig. 3)
are strikingly similar, but they do not indicate
any similarity to the organic moieties present
in aflatoxin B1. The infrared absorptions
(CHC13) at 905, 1,125, 1,360, 1,608, 1,767,
and 3,578 cm1 indicate the presence of
alkane group, ether linkage, CH3 bending,
C=C and C=O stretching and intra-
molecular hydroxy bending.
Biological testing. All the day-old ducklings
receiving 10 ig aflatoxin Bi/day died on the
4th and 5th day and had developed typical
biiary fibrosis and moderate fatty liver as
described earlier (12). The control birds as
well as the birds fed the urinary compound
were apparently healthy on the 5th day, and
their livers showed no abnormality.
It may be significant in this context that in
all the four children with the milder stages of
the disease, the compound was absent in the
urine, whereas in those who were in the ad-
vanced stages, the compound was invariably
present. It may also be significant that the
compound was present in subjects suffering
from other types of liver disorders. Whether
Fio. 2. Excitation and emission spectra of afla-
toxin B, (- - - -) and the compound appearing in
the urine of cirrhotic children (-----).
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Fic. 3. Infrared spectra of afiatoxin B, (- - - -)
and the compound present in urine of cirrhotic chil-
dren (---).
the compound is an abnormal metabolite or a
normal metabolite that is excreted in large
amounts because of altered liver function has
to be investigated. Since most subjects had
had, or were receiving, steroids, the possi-
bility of the fluorescent compound being a
steroid or its breakdown product was con-
sidered. The infrared and ultraviolet spectra
did not suggest that this compound was of
steroid origin. More direct evidence was also
obtained by giving steroids (prednisolone) to
both normal children as well as to some chil-
dren with grade I cirrhosis who had no spot in
the urine. After 3 days of steroid therapy, no
fluorescent spot was detected.
All these data on the physical and biological
properties strongly suggest that the compound
appearing in the urine, and also seen in the
liver of cirrhotic patients, is chemically quite
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different from aflatoxin B1 and its metabolites.
It is obviously not a steroid. Further work is
now in progress to identify the compound and
assess the significance of its presence in sub-
jects with liver disease.
SUMMARY
The possible etiological role of aflatoxin in
Indian childhood cirrhosis was investigated.
The chloroform extracts of urine and liver of
children with Indian childhood cirrhosis
showed a blue-violet fluorescent spot on thin-
layer chromatograms on silica gel having an
R, almost identical to that of aflatoxin B1.
The ultraviolet and infrared spectra of this
compound were different from aflatoxin B1.
It was also distinguishable from aflatoxin B1
in the fluorescent properties as evidenced by
absorption spectra. Unlike aflatoxin B1, the
compound was highly soluble in ethyl ether.
The biological test using day-old ducklings
further confirmed the nonidentity of the
fluorescent component appearing in the urine
of cirrhotic patients with aflatoxin B1.
The authors thank Dr. C. Rukmini and Mr.
Surendra Prasad for their help with the spectroscopic
analysis and Dr. D. Krishnamurthy for his help with
the liver biopsy sections.
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